Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 358
Filter
1.
Rev. cuba. reumatol ; 23(1): e870, tab
Article in Spanish | LILACS, CUMED | ID: biblio-1280402

ABSTRACT

Introducción: La COVID-19 causa una variada gama de manifestaciones clínicas. En pacientes con enfermedades reumáticas destacan, además de las manifestaciones respiratorias, las manifestaciones articulares, dermatológicas, generales y cardiovasculares. Objetivo: Identificar las manifestaciones cardiovasculares que con mayor frecuencia se presentan en pacientes con enfermedades reumáticas afectados por la COVID-19. Métodos: Se realizó una investigación básica, no experimental, con alcance exploratorio, descriptivo y explicativo de un universo constituido por 37 pacientes con diagnóstico previo de enfermedad reumática y diagnóstico confirmado de COVID-19. Se empleó la observación dirigida y la revisión documental como técnicas de investigación para identificar la presencia de manifestaciones cardiovasculares en este tipo de pacientes. Resultados: Predominaron las pacientes femeninas (59,56 por ciento), con diagnóstico de osteoartritis (72,97 por ciento) y artritis reumatoide (72,97 por ciento) y con comorbilidades asociadas (83,78 por ciento). La hipertensión arterial (61,29 por ciento) y el hipotiroidismo (38,71 por ciento) fueron las comorbilidades más frecuentes. El 70,27 por ciento de los pacientes presentaron manifestaciones cardiovasculares: hipertensión arterial (65,38 por ciento), trastornos del ritmo cardiaco (57,69 por ciento) y el síndrome de Raynaud (53,85 por ciento). El 80,0 por ciento de los pacientes masculinos presentaron manifestaciones cardiovasculares, al igual que el 80,64 por ciento de los casos con enfermedad reumática, COVID-19 y comorbilidades asociadas. Conclusiones: Las manifestaciones cardiovasculares se presentaron con elevada frecuencia en los pacientes reumáticos con diagnóstico de COVID-19, sobre todo pacientes masculinos con comorbilidades asociadas. Las manifestaciones cardiovasculares más frecuentes fueron la hipertensión arterial, los trastornos del ritmo y el síndrome de Raynaud(AU)


Introduction: COVID-19 generates a wide range of clinical manifestations in general. In patients with rheumatic diseases, in addition to respiratory manifestations, joint, dermatological, general and cardiovascular manifestations, among others, stand out. Objective: To identify the cardiovascular manifestations that most frequently occur in patients with rheumatic diseases and COVID-19. Methods: A basic, non-experimental research was carried out, with an exploratory, descriptive and explanatory scope. Universe made up of 37 patients with a previous diagnosis of rheumatic disease and a confirmed diagnosis of COVID-19. Directed observation and documentary review were used as research techniques to identify the presence of cardiovascular manifestations in this type of patient. Results: Predominance of female patients (59.56 percent), diagnosed with osteoarthritis (72.97 percent) and rheumatoid arthritis (72.97 percent) and with associated comorbidities (83.78 percent). Hypertension (61.29 percent) and hypothyroidism (38.71 percent) were the most frequent comorbidities. 70.27 percent of the patients presented cardiovascular manifestations, predominantly arterial hypertension (65.38 percent), rhythm disorders (57.69 percent) and Raynaud´s syndrome (53.85 percent). 80.0 percent of the male patients presented cardiovascular manifestations, as did 80.64 percent of the cases with rheumatic disease, COVID-19 and associated comorbidities. Conclusions: Cardiovascular manifestations occurred with high frequency in rheumatic patients diagnosed with COVID-19; being more frequent in male patients and with associated comorbidities. High blood pressure, rhythm disorders and Raynaud's syndrome were the most frequent(AU)


Subject(s)
Humans , Arthritis, Rheumatoid/complications , Signs and Symptoms , Cardiovascular Diseases/complications , Coronavirus Infections/complications , Early Diagnosis , Research Design
2.
Arq. bras. oftalmol ; 84(1): 87-90, Jan.-Feb. 2021. graf
Article in English | LILACS | ID: biblio-1153099

ABSTRACT

ABSTRACT This is a rare case report of acute, paracentral corneal melting and perforation occurring 1 week after an uneventful cataract surgery, with discussions on possible pathogenetic mechanisms. Relevant literature was also reviewed. Herein, a case of an 86-year-old woman with acute, paracentral, and sterile corneal melting and perforation in her left eye at 1 week after an uncomplicated cataract extraction is described. This occurs at the base of ocular surface disorders due to previous radiation of her lower eyelid and cheeks for the treatment of cancer and previously undiagnosed rheumatoid arthritis. She underwent surgical treatment using Gundersen's conjunctival flap for the existing perforation due to low visual expectancies and reluctance to undergo corneal keratoplasty due to the risk of corneal graft rejection. The risk of coming across an acute corneal melting after an uncomplicated cataract surgery in the eyes with ocular surface disorders should always be considered.


RESUMO É apresentado um caso raro de ceratomalácia paracentral aguda estéril e perfuração da córnea em uma paciente de 86 anos, uma semana após cirurgia para catarata sem intercorrências. Também são discutidos possíveis mecanismos de patogênese e a literatura relevante é revisada. Esses distúrbios da superfície ocular ocorreram devido à irradiação da pálpebra inferior e da bochecha em um tratamento de câncer e a uma artrite reumatoide não diagnosticada anteriormente. A paciente submeteu-se a um tratamento cirúrgico com um flap conjuntival de Gundersen sobre a perfuração existente, devido às suas baixas expectativas visuais e à relutância em submeter-se a uma ceratoplastia da córnea, considerando o risco de rejeição do enxerto corneano. Deve-se sempre considerar o risco de ocorrência de ceratomalácia aguda após cirurgias de catarata sem complicações em olhos apresentando distúrbios da superfície ocular.


Subject(s)
Humans , Female , Aged, 80 and over , Arthritis, Rheumatoid , Radiation , Cataract Extraction , Corneal Diseases , Arthritis, Rheumatoid/complications , Corneal Diseases/surgery , Corneal Diseases/etiology
3.
Braz. J. Pharm. Sci. (Online) ; 57: e19156, 2021. tab, graf
Article in English | LILACS | ID: biblio-1350240

ABSTRACT

Rheumatoid arthritis is an autoimmune inflammatory joint disease with global prevalence of 0.4% to 1.0%. Extra-articular manifestations increase its morbidity and severity, and cardiovascular diseases present the greatest risk. Therapeutic approaches have been used to treat rheumatoid arthritis, often involving the use of multiple classes of drugs with different mechanisms and forms of action. Corticosteroid therapy is widely used in this therapeutic combination; however, its use has been widely questioned because of its high toxicity and some negative effects, including the possibility of increased cardiovascular risk, depending on the dosage. Some studies have provided important insights into how glucocorticoids have an impact on cardiac complications in patients with rheumatoid arthritis. Most of these studies have concluded that exposure to these drugs at high or cumulative doses is associated with increased risk of death, as well as possibly being associated with the presence of a positive rheumatoid factor.


Subject(s)
Arthritis, Rheumatoid/complications , Cardiovascular Diseases/complications , Heart Disease Risk Factors , Glucocorticoids/adverse effects , Patients , Rheumatoid Factor , Pharmaceutical Preparations , Therapeutic Approaches
4.
Rev. cuba. reumatol ; 22(3): e852, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1149925

ABSTRACT

Al igual que en las enfermedades autoinmunes y reumáticas, las infecciones por virus pueden ser disparadores de mecanismos inmunopatogénicos. El SARSCoV-2 puede causar la liberación de citocinas y provocar un daño tisular grave, sobre todo pulmonar, con peligro para la vida. Se suma a ello el riesgo del uso de medicamentos inmunosupresores, empleados en los protocolos de tratamiento de las afecciones autoinmunes y también contra la infección viral de COVID-19. Hoy no contamos con conocimientos y evidencias científicas suficientemente sólidas para el enfrentamiento a la COVID-19, y cómo puede impactar entre los pacientes inmunodeprimidos por afecciones reumáticas. El Grupo Nacional de Atención y Enfrentamiento a la COVID-19 de la Sociedad Cubana de Reumatología se propuso elaborar un documento científico actualizado con las bases teórico-prácticas que permita acceder al conocimiento acerca de la infección por SARSCoV-2 y la COVID-19, y su repercusión sobre los pacientes con enfermedades autoinmunes y reumáticas para esbozar una estrategia de trabajo y ofrecer recomendaciones para los reumatólogos y pacientes cubanos. Se realizó un estudio de revisión y actualización acerca de la asociación entre las enfermedades reumáticas y autoinmunes y la COVID-19. Se emplearon las palabras clave enfermedades reumáticas, lupus eritematoso sistémico, artritis reumatoide, virus SARSCoV-2 y COVID-19. Se realizó una amplia búsqueda en MEDLINE y LILACS, y se revisaron más de 150 artículos, boletines de actualización de los sitios Web, páginas de salud de Cuba, resúmenes seleccionados por su calidad metodológica, revisiones y metaanálisis sobre el tema. A partir de la información recogida, se estableció una discusión y análisis considerando las principales experiencias internacionales, criterios de expertos, experiencias previas con otros virus en el Sistema de Salud de Cuba, con la participación de su red de científicos liderados por la Sociedad Cubana de Reumatología y su Grupo Nacional y el apoyo de la comunidad de reumatólogos(AU)


The outbreak of the infection by the new coronavirus SARSCoV-2, COVID-19, in December in Wuhan Province of China, has become a pandemic and health emergency given the deficiency of antiviral therapy for the acute respiratory syndrome that generates danger to life. The debut of the epidemic was in China, then the epicenter developed in Europe, northern Italy that suffered a severe blow. Worldwide, more than 10 million people are infected with the virus that has impacted on health systems until it practically collapsed, resulting in thousands of deaths. Today the epicenter of the pandemic has shifted to the Americas. Alarming figures highlight the United States of North America with some 2,737,600 infected and more than 128,471 deaths, followed by the South American giant Brazil with 1.3 million infections and 57,659 deaths. The Caribbean has a better setting. In Cuba, by the end of June, 2,340 cases of patients infected with deaths from COVID-19 were reported. We conducted a review, analysis and evaluation study of more than 150 articles from international journals, update bulletins of the WEB sites, health pages of the MINSAP of Cuba, and summaries selected for their methodological quality, and reviews, on the subject COVID-19 and autoimmune-rheumatic diseases by MEDLINE: database prepared by the National Library of Medicine of The USA contains bibliographic references and abstracts from more than 4,000 biomedical journals published in the United States and in 70 other countries, We also use Latin American and Caribbean Center for Information on Health Sciences: System, in Latin America and the Caribbean, since 1982. Our objective and results achieved have been to develop the theoretical-practical bases in an updated scientific document that allow access in an essential and summarized way to current knowledge about the infection by SACOV-2, COVID-19, and its repercussion and impact on patients suffering from rheumatic autoimmune diseases, and thus outline a coping and action strategy with recommendations for the Cuban rheumatologists in their health care work, and for patients as a guideline, given their well-founded concerns and fears given their underlying condition and the immunosuppressive drugs prescribed in an unfavorable context of a pandemic. The information is based on international experiences with the most published scientific evidence and those treasured national experiences in the face of similar situations of epidemics, faced by the vast health system and achievements of Cuban science(AU)


Subject(s)
Humans , Arthritis, Rheumatoid/complications , Autoimmune Diseases/complications , Adaptation, Psychological , Coronavirus Infections/complications , Lupus Erythematosus, Systemic/complications , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use
5.
Rev. cuba. reumatol ; 22(2): e783, mayo.-ago. 2020. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1126805

ABSTRACT

Introducción: La artritis reumatoide es una enfermedad reumática que genera distintos grados de discapacidad y afectación de la calidad de vida. A pesar de ello, no se describe como causa de lesiones en la cavidad bucal. Objetivo: Identificar las principales afectaciones de la cavidad bucal en pacientes con artritis reumatoide. Métodos: Estudio descriptivo, correlacional y de corte longitudinal que incluyó a 103 pacientes con diagnóstico de artritis reumatoide atendidos en la Unidad Móvil número 2 de Alausi en el periodo de enero a diciembre de 2019. A cada paciente se le realizó un examen estomatológico inicial y seguimiento mensual durante 6 meses para identificar las lesiones bucales, su tratamiento y rehabilitación. Resultados: Hubo un promedio de edad de 56,67 años, con predominio de pacientes entre 40 y 59 años (49,51 por ciento), del sexo femenino (71,84 por ciento) y con tiempo de evolución menor de 3 años (57,28 por ciento). El 44,66 por ciento de los casos presentó comorbilidades asociadas; el sobrepeso fue la más frecuente (41,30 por ciento). El 84,47 por ciento de los pacientes tenía lesiones de la cavidad bucal: adentia parcial (33,33 por ciento) y gingivitis crónica (19,54 por ciento). El 43,69 por ciento tenía un nivel de conocimiento bajo acerca de la prevención de lesiones bucales. Conclusiones: Existió una elevada prevalencia de lesiones de la cavidad bucal en pacientes con artritis reumatoide. La adentia parcial, las caries dentales, la gingivitis crónica y las lesiones premalignas fueron las más frecuentes. Se halló una correlación positiva media entre el tiempo de evolución de la enfermedad y la presencia de lesiones de la cavidad bucal(AU)


Introduction: Rheumatoid arthritis is a rheumatic, autoimmune, inflammatory and chronic disease that, due to the varied number of clinical manifestations and complications, generates different degrees of disability and impaired quality of life. Objective: To identify the main effects of the oral cavity in patients with rheumatoid arthritis. Methodology: Descriptive, correlational and longitudinal sectional study that included 103 patients diagnosed with rheumatoid arthritis treated in the Mobile Unit number 2 of Alausi. Each patient underwent an initial stomatological examination and monthly follow-up for a period of 6 months that allowed the identification of oral lesions, their treatment and oral rehabilitation. Results: Average age of 56.67 years with a predominance of patients between 40 and 59 years (49.51 percent), of the female sex (71.84 percent) and with evolution time less than 3 years (57.28 percent). 44.66 percent of the cases presented associated comorbidities, being overweight the most frequent (41.30 percent). 84.47 percent of the patients presented oral cavity lesions, with partial adentia (33.33 percent) and chronic gingivitis (19.54 percent) being the most represented. 43.69 percent of the patients presented low level of knowledge about prevention of oral lesions. Conclusions: There was a high prevalence of lesions of the oral cavity in patients with rheumatoid arthritis. Partial adentia, dental caries, chronic gingivitis, and premalignant lesions were the most significant. A mean positive correlation was found between the evolution time of the disease and the presence of lesions of the oral cavity(AU)


Subject(s)
Humans , Male , Female , Arthritis, Rheumatoid/complications , Dental Caries , Mouth/injuries , Mouth Diseases/prevention & control , Epidemiology, Descriptive , Longitudinal Studies , Ecuador
6.
Rev. chil. pediatr ; 91(4): 521-528, ago. 2020. tab
Article in Spanish | LILACS | ID: biblio-1138666

ABSTRACT

Resumen: Introducción: Al menos 50% de los pacientes pediátricos portadores de artritis idiopática juvenil (AIJ) continuará control en reumatología adulto. La clasificación de la Liga Internacional de Asociaciones de Reumatología (ILAR) vigente, actualmente en revisión, difiere de la clasificación de las artritis inflamatorias del adulto. Se ha reportado cambios de categoría en 10,8% de los pacientes durante el seguimiento. Objetivo: Analizar los pacientes con AIJ seguidos al menos 7 años para objetivar cambios de diagnós tico en la transición, e identificar factores de mal pronóstico funcional. Pacientes y Método: Estudio retrospectivo en base a registros clínicos. Se incluyó a la totalidad de los pacientes con AIJ controla dos en policlínico pediátrico del Hospital de Puerto Montt entre el año 2005 y 2017, que cumplieron siete o más años de seguimiento. Se realizó análisis descriptivo en base a variables clínicas: categoría diagnóstica, tiempo de evolución al diagnóstico, actividad clínica y serológica, y tiempo de evolución al inicio de la terapia farmacológica. Resultados: Se evaluaron 18 pacientes, 3 Oligo-articular (OA) persistente, 1 OA extendida, 4 Poli-articular (PA) factor reumatoide (FR) negativo, 4 PA FR positivo, 5 Sistémicas, 1 Psoriática, todos con seguimiento mayor a 7 años. Once de 18 niños fueron transfe ridos a adultos. Tres de 11 cambiaron de diagnóstico a Artritis Reumatoide (AR) más otra enferme dad autoinmune: Síndrome de Sjögren + Lupus eritematoso sistémico, Púrpura trombocitopénico inmune, Enfermedad autoinmune no clasificada y cinco de 11 niños de categoría ILAR: OA a Artritis reumatoide juvenil, OA extendida a PA FR negativo, 3 Sistémicas a PA FR negativo. Edad de inicio, formas poli-articulares, retrasos en diagnóstico y comienzo de terapia se asociaron a secuelas e infla mación persistente. Conclusiones: Ocho de once pacientes transferidos cambiaron denominación diagnóstica y/o presentaron otras enfermedades autoinmunes. Algunos factores de mal pronóstico deben mejorar.


Abstract: Introduction: At least 50% of pediatric patients with Juvenile Idiopathic Arthritis (JIA) will require continued fo llow-up in adult rheumatology. The present International League of Associations for Rheumatology (ILAR) classification, currently under revision, differs from its classification of inflammatory arthritis in adults. Category changes have been reported in 10.8% of patients during follow-up. Objective: To analyze JIA patients in follow-up for at least 7 years to detect diagnosis changes during transition to adult care, identifying factors of poor functional prognosis. Patients and Method: Retrospective study based on medical records of JIA patients seen at the pediatric polyclinic of the Puerto Montt Hospital between 2005 and 2017, who were monitored for at least 7 years. Descriptive analysis was performed according to clinical variables: diagnostic category, evolution before diagnosis, clinical and serological activity, and evolution before starting drug therapy. Results: We evaluated 18 pa tients, corresponding to 3 patients with persistent oligoarticular arthritis (OA), 1 with extended OA, 4 with polyarticular arthritis (PA) rheumatoid factor (RF) negative, 4 with PA RF positive, 5 with syste mic JIA, and 1 with psoriatic arthritis, all have had follow-up more than 7 years. 11 out of 18 patients transitioned to adult care. Three out of 11 patients changed diagnosis to Rheumatoid Arthritis (RA) plus another autoimmune disease such as Sjögren's Syndrome + Systemic Lupus Erythematosus, Immune thrombocytopenia, or unclassified autoimmune disease, and 5 out of 11 children changed ILAR category from OA to Juvenile Rheumatoid Arthritis, extended OA to PA RF negative, and 3 from Systemic arthritis to PA RF negative. Age of onset, polyarticular forms, delay in diagnosis, and the start of therapy were associated with sequelae and persistent inflammation. Conclusions: Eight of the eleven JIA patients who transitioned to adult care changed their diagnosis or presented other autoimmune diseases. Some factors of poor prognosis must improve.


Subject(s)
Humans , Male , Female , Young Adult , Arthritis, Juvenile/diagnosis , Transition to Adult Care , Arthritis, Juvenile/classification , Arthritis, Juvenile/complications , Arthritis, Juvenile/therapy , Arthritis, Rheumatoid/classification , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/diagnosis , Arthritis, Rheumatoid/therapy , Prognosis , Arthritis, Psoriatic/complications , Arthritis, Psoriatic/diagnosis , Arthritis, Psoriatic/therapy , Retrospective Studies , Follow-Up Studies , Purpura, Thrombocytopenic, Idiopathic/complications , Purpura, Thrombocytopenic, Idiopathic/diagnosis , Purpura, Thrombocytopenic, Idiopathic/therapy , Aftercare , Disease Progression , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis , Lupus Erythematosus, Systemic/therapy
7.
Rev. cuba. reumatol ; 21(3): e97, sept.-dic. 2019. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1093828

ABSTRACT

Introducción: las enfermedades reumáticas son consideradas como un grupo de afecciones que se presentan principalmente en personas mayores de 40 años de edad, aunque pueden presentar en edades tempranas de la vida. Se describen una serie de factores que pueden precipitar la aparición de las mismas, dentro de estos se mencionan a las enfermedades endocrino metabólicas y principalmente la diabetes mellitus. Objetivo: describir la relación existente entre las enfermedades reumáticas y la diabetes mellitus. Método: estudio descriptivo en 827 pacientes con enfermedades reumáticas según los criterios del Colegio Americano de Reumatología para describir la relación entre las enfermedades reumáticas y la diabetes mellitus. Se utilizó coeficiente de correlación de Pearson para determinar la relación existente entre ambas afecciones. Resultados: promedio de edad general de 53,28 años y de pacientes con diabetes de 63,57 años. Predominio de pacientes femeninas (80,17 por ciento), de pacientes con osteoartritis (50,55 por ciento) y con tiempo de evolución entre 3 y 5 años. El 30,96 por ciento de los casos presentó diabetes mellitus confirmada, con predominio de incidencia en pacientes con lupus (40,74 por ciento), artritis reumatoide (40,55 por ciento) y osteoartritis (32,06 por ciento). En el 66,36 por ciento el diagnóstico de diabetes mellitus previno al de la enfermedad reumática. Conclusiones: existe una correlación positiva media entre la presencia de diabetes mellitus y las enfermedades reumáticas, ambas incorporan componentes inmunológicos como parte de su mecanismo etiopatogénico, sin embargo, no queda claro cuál es el nivel interacción entre ellas(AU)


Introduction: rheumatic diseases are considered as a group of conditions that occur mainly in people over 40 years of age, although they can present at early ages of life. A series of factors that can precipitate the appearance of these are described, within these are mentioned endocrine metabolic diseases and mainly diabetes mellitus. Objective: to describe the relationship between rheumatic diseases and diabetes mellitus. Method: descriptive study in 827 patients with rheumatic diseases according to the criteria of the American College of Rheumatology to describe the relationship between rheumatic diseases and diabetes mellitus. Pearson's correlation coefficient was used to determine the relationship between both conditions. Results: average age of 53.28 years and of patients with diabetes of 63.57 years. Predominance of female patients (80.17 percent), of patients with osteoarthritis (50.55 percent)) and with evolution time between 3 and 5 years. The 30,96 percent) of the cases presented diabetes mellitus confirmed, with predominance of incidence in patients with lupus (40,74 percent)), rheumatoid arthritis (40,55 percent)) and osteoarthritis (32,06 percent)). In 66.36 percent) the diagnosis of diabetes mellitus prevented that of rheumatic disease. Conclusions: there is a media positive correlation between the presence of diabetes mellitus and rheumatic diseases, both incorporate immunological components as part of their etiopathogenic mechanism, however, it is not clear what is the interaction level between them(AU)


Subject(s)
Humans , Arthritis, Rheumatoid/complications , Diabetes Complications/epidemiology , Rheumatic Diseases , Epidemiology, Descriptive , Metabolic Diseases
8.
Rev. cuba. reumatol ; 21(3): e106, sept.-dic. 2019. tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1093832

ABSTRACT

Introducción: la artritis reumatoide es una enfermedad sistémica, de etiología desconocida, caracterizada por provocar inflamación crónica, cursa con manifestaciones articulares, extrarticulares y comportamiento clínico variable. Objetivo: caracterizar los factores de riesgo para la aparición de aterosclerosis en pacientes con artritis reumatoide e identificar su relación con el tiempo de diagnóstico, actividad inflamatoria y tratamiento. Método: se realizó estudio descriptivo transversal, en pacientes con artritis reumatoide atendidos en el Centro de Reumatología del Hospital Docente Clínico Quirúrgico 10 de Octubre entre febrero 2016 y junio 2017. Resultados: la mayor frecuencia fue para el sexo femenino, el rango etario 45-54 años. Se observó placa ateromatosa en 37.2 por ciento y engrosamiento complejo íntima media en el 15.4 por ciento. Los factores de riesgo que mostraron asociación con la presencia de placa fueron: hipertrigliceridemia (p= 0.000), hipercolesterolemia (p= 0.000), Diabetes Mellitus (p= 0.027) y los niveles elevados de proteína C Reactiva (p= 0.003). Conclusiones: los factores de riesgo tradicionales que presentaron significación estadística fueron la hipercolesterolemia, hipertrigliceridemia y la Diabetes Mellitus. La presencia de más de un factor elevó la frecuencia de alteraciones en el eco doppler; existió asociación entre la elevación de los niveles de PCR y la presencia de alteraciones del eco doppler. Se constató en aquellos pacientes con alteraciones eco doppler carotídeo relación con el tiempo de evolución, actividad de la enfermedad y dosis acumulada de esteroides(AU)


Introduction: rheumatoid arthritis is a systemic disease, of unknown etiology, characterized by chronic inflammation; It presents with joint, extra-articular manifestations and variable clinical behavior. Objective: to characterize the risk factors for the appearance of atherosclerosis in patients with rheumatoid arthritis and to identify their relationship with the time of diagnosis, inflammatory activity and treatment. Method: a cross-sectional, descriptive study was conducted in patients with rheumatoid arthritis treated at the Rheumatology Center of the Surgical Clinical Teaching Hospital 10 de Octubre in the period between February 2016 and June 2017. Results: the highest frequency was for the female sex, the age range 45-54 years. Atheromatous plaque was observed in 37.2 percent and intimal complex thickening in 15.4 percent. The risk factors that showed association with the presence of plaque were: hypertriglyceridemia (p= 0.000), hypercholesterolemia (p= 0.000), Diabetes Mellitus (p= 0.027) and high levels of C-reactive protein (p= 0.003) Conclusions: the traditional risk factors that presented statistical significance were hypercholesterolemia, hypertriglyceridemia and Diabetes Mellitus. The presence of more than one traditional risk factor increased the frequency of alterations in Doppler echo; There was an association between the elevation of C-Reactive Protein levels and the presence of Doppler echo alterations. It was found in those patients with carotid echo Doppler alterations, relationship with the time of evolution, activity of the disease and cumulative dose of steroids(AU)


Subject(s)
Humans , Arthritis, Rheumatoid/complications , C-Reactive Protein/analysis , Hypertriglyceridemia/complications , Polymerase Chain Reaction/methods , Diabetes Mellitus/diagnosis , Atherosclerosis/complications , Hypercholesterolemia/complications , Epidemiology, Descriptive , Cross-Sectional Studies , Risk Factors
9.
Rev. cuba. reumatol ; 21(2): e86, mayo.-ago. 2019. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1093810

ABSTRACT

Introducción: el hipotiroidismo es una enfermedad sistémica, crónica caracterizada por la disminución de la producción de hormonas tiroideas, en muchas ocasiones el trastorno inmunológico forma parte del mecanismo etiopatogénico de la enfermedad. Se asocian con otras enfermedades autoinmunes como es el caso de la artritis reumatoide, generando de esta forma un complejo cortejo sintomático en el que ambas afecciones pueden coexistir provocando importantes grados de discapacidad funcional y de disminución de la percepción de calidad de vida relacionada con la salud. Objetivo: describir la relación existente entre las enfermedades tiroideas y la artritis reumatoide. Método: estudio descriptivo en 265 pacientes con artritis reumatoide según los criterios del Colegio Americano de Reumatología para describir la relación entre esta enfermedad y los trastornos de la glándula tiroides. Se utilizó coeficiente de correlación de Pearson para determinar la relación existente entre ambas afecciones. Resultados: promedio de edad general de 58,39 años y de pacientes con hipotiroidismo de 66,32 años. Predominio de pacientes femeninas (76,98 por ciento ) y con tiempo de evolución entre 3 y 5 años. El 29,81 por ciento de los casos presentó diagnóstico de hipotiroidismo confirmado, con predominio en pacientes femeninas (86,08 por ciento ), edad mayor de 65 años (49,37 por ciento ) y tiempo de evolución de la artritis reumatoide mayor de cinco años (53,16 por ciento ). Conclusiones: existe un elevado por ciento de pacientes con hipotiroidismo y artritis reumatoide; aunque ambas afecciones comparten mecanismos inmunológicos comunes, no se encuentra una relación directa entre ambas, no pudiéndose establecer una relación causa efecto entre ambas afecciones(AU)


Introduction: hypothyroidism is a systemic, chronic disease characterized by decreased production of thyroid hormones, in many cases the immune disorder is part of the etiopathogenic mechanism of the disease. They are associated with other autoimmune diseases such as rheumatoid arthritis, thus generating a complex symptomatic courtship in which both conditions can coexist leading to significant degrees of functional disability and decreased perception of quality of life related to health. Objective: to describe the relationship between thyroid diseases and rheumatoid arthritis. Method: descriptive study in 265 patients with rheumatoid arthritis according to the criteria of the American College of Rheumatology to describe the relationship between this disease and disorders of the thyroid gland. Pearson's correlation coefficient was used to determine the relationship between both conditions. Results: average age of 58.39 years and of patients with hypothyroidism of 66.32 years. Predominance of female patients (76.98 percent) and with evolution time between 3 and 5 years. The 29.81 percent of the cases presented a diagnosis of confirmed hypothyroidism, with predominance in female patients (86.08 percent), age over 65 years (49.37 percent) and time of evolution of rheumatoid arthritis greater than five years (53.16 percent). Conclusions: there is a high percentage of patients with hypothyroidism and rheumatoid arthritis; although both conditions share common immunological mechanisms, there is no direct relationship between the two, and a causal relationship can´t be established between the two conditions(AU)


Subject(s)
Humans , Middle Aged , Arthritis, Rheumatoid/complications , Quality of Life , Autoimmune Diseases , Hypothyroidism/complications , Immune System Diseases
10.
Rev. méd. Chile ; 147(6): 762-775, jun. 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1020725

ABSTRACT

Rheumatoid arthritis (RA) and chronic periodontitis (CP) may be related due to a bidirectional etiology. The evidence shows that CP could alter the clinical course of RA. We performed a systematic search to determine if CP alters the morbidity of RA, analyzing its clinical and molecular aspects. Of 552 initial articles found, 16 were selected for a thorough review. There is a greater prevalence of CP in patients with RA. Patients with RA have significantly higher values of periodontal clinical parameters than healthy controls. Arthritis activity is significantly greater in patients who suffer from CP and decreases with nonsurgical periodontal treatment. There is a significant relationship between the severity of CP and RA activity.


Subject(s)
Humans , Male , Female , Arthritis, Rheumatoid/complications , Chronic Periodontitis/complications , Arthritis, Rheumatoid/physiopathology , Arthritis, Rheumatoid/therapy , Biomarkers , Case-Control Studies , Risk Factors , Chronic Periodontitis/physiopathology , Chronic Periodontitis/therapy
11.
The Egyptian Journal of Hospital Medicine ; 77(3): 5148-5154, 2019. ilus
Article in English | AIM | ID: biblio-1272791

ABSTRACT

Background: Rheumatoid arthritis (RA) is the most common autoimmune disease. Ocular manifestations of RAvary and are mainly keratoconjunctivitis sicca, episcleritis, scleritis and keratitis. Antimalarial drugs [hydroxychloroquine (HCQ) and chloroquine (CQ)] have been used for the treatment of RA. Objective: The aim of this study was to study the ocular manifestations of rheumatoid arthritis and the complications of the use of hydroxychloroquine in treatment. Patients and methods: A prospective study that was conducted at Al-Zahraa University Hospital. The study included a total of 80 eyes of 40 patients. Patients were divided into two groups: Group (1) 20 RA patients not using HCQ treatment and group (2) 20 RA patients using HCQ treatment. All patients underwent complete ophthalmic examination including SD-OCT. Results: the most ocular manifestations found in patients were keratoconjunctivitis sicca (KCS) 93.8%, scleritis and episcleritis 2.5%, acute anterior uveitis (AAU) and sclerosing keratitis 1.3%. Regarding SD-OCT finding comparing between the two groups, we found signs of early HCQ retinopathy in patients of group 2 in the form of parafoveal and perifoveal thining compared to group 1. Conclusion: RA is associated with many extra-articular manifestations, HCQ and CQ used in treatment of RA have significant efficacy and safety, but with long duration of using can cause retinopathy, and follow up of patients is necessary to detect early retinopathy


Subject(s)
Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/therapy , Egypt , Eye , Hydroxychloroquine
12.
Rev. cuba. reumatol ; 21(supl.1): e66, 2019.
Article in Spanish | LILACS, CUMED | ID: biblio-1099113

ABSTRACT

Introducción: La artritis reumatoide es una enfermedad inflamatoria sistémica y crónica que, aunque suele tener su pico de incidencia en edades superiores, también puede presentar en edades más tempranas de la vida. La gestación es estas pacientes es considerada una situación de elevado riesgo debido a la misma actividad de la enfermedad y al posible efecto teratogénico que pueden devenirse del uso de muchos de los fármacos que generalmente se utilizan en estos casos. Sin embargo, una correcta planificación, un adecuado seguimiento ginecobstétrico y reumatológico y la valoración sistemática de la actividad de la enfermedad, constituyen los elementos básicos de la atención médica durante este periodo. Objetivo: dar a conocer los elementos fundamentales del seguimiento de la gestación en pacientes con artritis reumatoide. Caso clínico: se presenta el caso de una paciente de 23 años de edad con diagnóstico de artritis reumatoide de 5 años de evolución que concibe una gestación que con todos los cuidados médicos se logra llegar a un feliz término. Conclusiones: al ser la artritis reumatoide una enfermedad de compleja evolución las pacientes jóvenes tienen cierto temor a la gestación, sin embargo, durante el embarazo se produce cierta mejoría clínica de la artritis. Es imprescindible garantizar la menor actividad posible para que no afecte el pronóstico y la salud materna y fetal(AU)


Introduction: Rheumatoid arthritis is a systemic and chronic inflammatory disease that, although it usually has its peak of incidence in older ages, can also present at younger ages of life. The pregnancy is these patients is considered a situation of high risk due to the same activity of the disease and the possible teratogenic effect that can be derived from the use of many of the drugs that are generally used in these cases. However, proper planning, adequate gynecobysteometric and rheumatological follow-up, and systematic assessment of disease activity are the basic elements of medical care during this period. Objective: to present the fundamental elements of the pregnancy follow-up in patients with rheumatoid arthritis. Clinical case: We present the case of a 23-year-old patient with a diagnosis of rheumatoid arthritis of 5 years of evolution who conceives a pregnancy that with all medical care is achieved a happy term. Conclusions: as rheumatoid arthritis is a disease of complex evolution young patients have some fear of pregnancy, however, during pregnancy there is some clinical improvement of arthritis. It is essential to guarantee as little activity as possible so that it does not affect prognosis and maternal and fetal health(AU)


Subject(s)
Humans , Female , Pregnancy , Young Adult , Pregnancy Complications/prevention & control , Arthritis, Rheumatoid/complications , Maternal Health , Planning
13.
Rev. cuba. reumatol ; 21(supl.1): e76, 2019. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1099121

ABSTRACT

Las investigaciones en la última década han demostrado que el riesgo de desarrollar linfoma en pacientes con artritis reumatoide es el doble que el riesgo de la población general. Sin embargo, no se cuenta con datos de la magnitud de este problema en Cuba. Se presentan los casos de tres pacientes con diagnóstico de artritis reumatoide seropositiva tratadas con metotrexate, que durante su evolución desarrollaron linfoma no Hodgkin. Las pacientes recibieron quimioterapia de primera línea y alcanzaron remisión total con supervivencia de tres años hasta el momento. El diagnóstico de las enfermedades linfoproliferativas en pacientes con artritis reumatoide es un desafío; por lo que es necesario un elevado índice de sospecha que, en ausencia de marcadores fiables de linfomagénesis, permita el manejo oportuno de estos pacientes(AU)


Research in the last decade has shown that the risk of developing lymphoma in patients with rheumatoid arthritis is twice the risk of the general population. However, there is not data on the magnitude of this problem in Cuba.We present the cases of three patients with a diagnosis of seropositive rheumatoid arthritis treated with methotrexate who during their evolution developed non-Hodgkin's lymphoma.The patients received first-line chemotherapy and they achieved total remission with three-year survival so far.The diagnosis of lymphoproliferative diseases in patients with rheumatoid arthritis is a challenge; therefore, a high index of suspicion is necessary that, in the absence of reliable markers of lymphomagenesis, allows the timely management of these patients(AU)


Subject(s)
Humans , Female , Adult , Middle Aged , Arthritis, Rheumatoid/complications , Lymphoma, Non-Hodgkin/complications , Lymphoma, Non-Hodgkin/drug therapy , Survival , Methotrexate/therapeutic use , Drug Therapy , Autoimmune Lymphoproliferative Syndrome/complications , Survivorship
14.
Rev. chil. reumatol ; 35(2): 55-58, 2019.
Article in Spanish | LILACS | ID: biblio-1281968

ABSTRACT

La artritis reumatoide (AR) es una enfermedad inflamatoria sistémica de origen autoinmune, caracterizada por una evolución variable, con remisiones y reacti-vaciones. Se considera que un diagnóstico y tratamiento precoz permiten evitar el daño articular, mejorar el pronóstico y la calidad de vida del paciente. El trata-miento actual está basado en el uso de fármacos antirreumáticos sintéticos mo-dificadores de la enfermedad (sDMARDS), asociado a glucocorticoides en dosis bajas. Frente al fracaso o intolerancia de este tratamiento o bien en casos de una enfermedad inicial muy severa, en especial con manifestaciones extraarticulares, se recomienda el uso de fármacos biológicos modificadores de la enfermedad (bDMARD). Estos fármacos, usados en las condiciones señaladas, han significado un avance importante en el control y pronóstico de la enfermedad. Sin embargo, no están exentos de la presencia de reacciones adversas, por lo que deben ser monitorizados permanentemente.


Rheumatoid arthritis (RA) is a systemic inflammatory disease of autoimmune ori-gin, characterized by a variable evolution, with remissions and reactivations. It is considered that a diagnosis and early treatment allow avoiding the joint damage, improving the prognosis and the quality of life of the patient. The current treat-ment is based on the use of synthetic antirheumatic drugs modifying the disease (sDMARDS), associated with low-dose glucocorticoids. Faced with the failure or intolerance of this treatment or in cases of a very severe initial disease, especially with extra-articular manifestations, the use of biological drugs that modify the disease (bDMARD) is recommended. These drugs, used in the indicated condi-tions, have meant an important advance in the control and prognosis of the dis-ease. However, they are not exempt from the presence of adverse reactions, so they should be monitored permanently.


Subject(s)
Humans , Female , Middle Aged , Arthritis, Rheumatoid/drug therapy , Antirheumatic Agents/adverse effects , Arthritis, Rheumatoid/complications , Biological Treatment , Antirheumatic Agents/therapeutic use , Glucocorticoids
15.
Rev. chil. reumatol ; 35(4): 158-160, 2019. ilus
Article in Spanish | LILACS | ID: biblio-1282356

ABSTRACT

El mayor acceso a las terapias biológicas para el tratamiento de múltiples enfer-medades autoinmune trae consigo el mayor riesgo de padecer eventos adversos relacionados al uso de estos2,4. Presentamos un caso clínico de una paciente con diagnóstico de artritis reumatoide en tratamiento con ANTI TNF


The greater access to biological therapies for the treatment of multiple autoim-mune diseases brings with it the greatest risk of suffering adverse events related to the use of these (2,4). We present a clinical case of a patient diagnosed with rheumatoid arthritis in treatment with ANTI TNF


Subject(s)
Humans , Female , Middle Aged , Lupus Erythematosus, Cutaneous/etiology , Tumor Necrosis Factor Inhibitors/adverse effects , Arthritis, Rheumatoid/complications , Autoimmune Diseases/therapy
16.
Rev. Hosp. Clin. Univ. Chile ; 30(1): 33-42, 2019.
Article in Spanish | LILACS | ID: biblio-1005576

ABSTRACT

Cardiovascular disease (CVD) is the most frequent cause of premature death according to data from the American Heart Association and World Health Organization. Incidence and prevalence are on the rise. Rheumatoid Arthritis (RA) is the most common autoimmune disease. It is a chronic and systemic disease characterized by articular involvement with deformity ranging from persistent pain to premature disability. CVD is the most frequent cause of death in RA patients, even more than in diabetes mellitus 2 or chronic kidney disease. Multiple CVD risk scales have been tested in order to obtain a more accurate prediction of premature death by stroke or myocardial infarction in RA patients. Most of the scales, even those adjusted including RA features like inflammation and antibodies titles, have failed to properly predict the real CVD risk. Individually, RA specific autoantibodies have been related with increased CVD risk and multiple mechanistic explanations have arisen, generating even a new concept called "Autoimmune Atheromatosis". Nevertheless, this association fails to give a full understanding of the accelerated and aggressive atheromatosis process that RA patients develop. New studies oriented to mechanistic explanations are necessary in order to develop new diagnostic targets and prevention strategies. (AU)


Subject(s)
Arthritis, Rheumatoid/drug therapy , Cardiovascular Diseases , Comorbidity , Arthritis, Rheumatoid/complications
17.
Acta ortop. mex ; 32(6): 342-346, nov.-dic. 2018. tab
Article in Spanish | LILACS | ID: biblio-1248616

ABSTRACT

Resumen: Introducción: La afectación de la columna cervical es común en pacientes con artritis reumatoide (AR), factores de riesgo como la actividad de la enfermedad puede estar relacionada con inestabilidad cervical asintomática. Objetivo: Determinar los factores asociados a la inestabilidad de la columna cervical asintomáticos en pacientes con artritis reumatoide. Material y métodos: Estudio de casos y controles provenientes de la consulta externa de reumatología y columna de un centro de trauma de nivel II para identificar a todos los pacientes diagnosticados con AR e inestabilidad cervical asintomáticos. Con radiografías simples de la columna cervical que hacen mediciones radiográficas, se realizó el diagnóstico de inestabilidad cervical, se evaluaron los factores de riesgo como la presencia de factor reumatoide (FR), cirugías articulares previas, las elevaciones de los valores de proteína C reactiva (PCR), la severidad y actividad de la enfermedad medida en el índice de actividad de la enfermedad de 28 articulaciones (DAS 28), además del índice de actividad de la enfermedad simplificada (SDAI). Resultados: Se evaluaron 32 pacientes, nueve (28.1%) cumplieron con los criterios para inestabilidad de la columna cervical con subluxación atlantoaxial anterior (SAAa) (100%), también un paciente con SAAa presentaba subluxación vertical (SV), los factores de riesgo más relevantes: el DAS 28 con un OR = 3.54, SDA con un OR = 2.34 y por último el PCR > 1.0 su OR = 2.88. Conclusión: Los factores de riesgo asociados oportunamente en nuestra población son la severidad de la actividad de la enfermedad que podemos observar en el DAS y SDAI al aplicarlos en los pacientes y PCR > 1.0.


Abstract: Introduction: Cervical spine involvement is common in patients with RA, risk factors such as disease activity may be related to asymptomatic cervical instability. Objective: To determine the associated factors for asymptomatic cervical spine instability in patients with rheumatoid arthritis. Material and methods: Case and control study from the external spine and rheumatology consultation of a level II trauma center to identify all patients diagnosed with rheumatoid arthritis (RA) and asymptomatic cervical instability. With simple X-rays of the cervical spine, carrying out radiographic measurements, the diagnosis of cervical instability was performed, risk factors such as the presence of rheumatoid factor (FR), previous articular surgeries, elevations of the C-reactive protein (PCR) values were evaluated. The severity and activity of the disease measured in the activity index of 28 articulations (DAS 28) in addition to the index of activity of the simplified disease (SDAI). Results: We assessed 32 patients, nine patients (28.1%) met the criteria for instability of the anterior cervical spine atlantoaxial subluxation (SAAa) (100%), also one patient with SAAa presented vertical subluxation (SV), risk factors more relevant: DAS 28 with an OR = 3.54, SDA with an OR = 2.34 and finally the PCR > 1.0 its OR = 2.88. Conclusion: The risk factors associated opportunely in our population are the severity of the activity of the disease that we can see in the DAS and SDAI when applied in patients and PCR > 1.0.


Subject(s)
Humans , Arthritis, Rheumatoid/complications , Cervical Vertebrae/pathology , Joint Dislocations , Joint Instability , Atlanto-Axial Joint
18.
Acta ortop. mex ; 32(4): 193-197, Jul.-Aug. 2018. tab
Article in English | LILACS | ID: biblio-1124093

ABSTRACT

Abstract: Background: Rheumatoid arthritis is a chronic inflammatory disease characterized by polyarthritis with progressive articular wear, immunologic abnormalities and increasing physical limitation. Surgical correction with hip replacement comes as a successful solution for patients with advanced articular destruction. Following intervention, surgical site infection (SSI), venous thromboembolism, sepsis, renal and major cardiovascular complications are among the most cited in the literature. No consensus exists as to the detection of preoperative hypoalbuminemia in patients with rheumatoid arthritis. Methods: This study retrospectively evaluated the preoperative serum albumin of 75 patients with rheumatoid arthritis and analyzed its relevance in terms of appearance of postoperative complications with a six-month follow-up. Complications in the group of patients with low serum albumin and the group of patients with normal serum albumin were reviewed to identify the effect of each variable. Odds ratio for each variable was calculated (hospital readmission, surgical site infection, renal and cardiac complications, non-infectious wound complications and the presence of residual hip pain), as well as p-value and confidence intervals. Results: Surgical site infection showed a statistically significant relation with low serum albumin (OR: 6.125, p = 0.018) as did non-infectious wound complications (OR: 3.714, p = 0.026) and residual hip pain (OR: 3.149, p = 0.022). Conclusion: Preoperative low serum albumin has a direct relation with the rate of postoperative complications including SSI, non-infectious wound complications (seroma formation, wound dehiscence) and residual hip pain. Preoperative serum albumin is a reliable marker of nutrition, which may establish preventive strategies to reduce postoperative complications in patients with rheumatoid arthritis.


Resumen: Introducción: La artritis reumatoide es una enfermedad inflamatoria crónica con desgaste articular progresivo, anomalías inmunológicas y aumento de la limitación física. La corrección quirúrgica con el reemplazo de la cadera es una solución a la destrucción articular avanzada. Después de la intervención, la infección del sitio quirúrgico (SSI), el tromboembolismo venoso, la sepsis y las complicaciones cardiovasculares o renales se encuentran entre las más citadas en la literatura. No existe consenso en cuanto a la detección de hipoalbuminemia preoperatoria en pacientes con artritis reumatoide. Métodos: Estudio retrospectivo evaluando la albúmina de suero preoperatoria de 75 pacientes con artritis reumatoide, se analizó su importancia en términos de complicaciones postoperatorias en los primeros seis meses de seguimiento. Las complicaciones en el grupo de pacientes con albúmina de suero baja y el grupo de pacientes con albúmina de suero normal fueron repasadas para identificar el efecto de cada variable. Se calculó el odds ratio para cada variable (reingreso hospitalario, infección del sitio quirúrgico, complicaciones renales y cardíacas, complicaciones no infecciosas de la herida y presencia de dolor de cadera residual), así como el valor p y los intervalos de confianza. Resultados: La infección del sitio quirúrgico demostró una relación estadística significativa con la albúmina de suero baja (o: 6.125, p = 0.018) al igual que complicaciones no infecciosas de la herida (o: 3.714, p = 0.026) y dolor residual de la cadera (o: 3.149, p = 0.022). Conclusión: La albúmina sérica baja preoperatoria tiene una relación directa con la tasa de complicaciones postoperatorias: infección, formación de seromas, dehiscencia de la herida y dolor residual.


Subject(s)
Humans , Arthritis, Rheumatoid/complications , Surgical Wound Infection/diagnosis , Surgical Wound Infection/blood , Serum Albumin/analysis , Arthroplasty, Replacement, Hip/adverse effects , Postoperative Complications , Retrospective Studies , Risk Factors
19.
Acta bioquím. clín. latinoam ; 52(1): 49-60, mar. 2018. graf, tab
Article in Spanish | LILACS | ID: biblio-886160

ABSTRACT

Se evaluó la relevancia clínica de analizar conjuntamente dos nuevos autoanticuerpos (anti-vimentina citrulinada mutada: anti-MCV y anti-peptidil arginina desaminasa 4: anti-PAD4) en conjunto con los utilizados clásicamente en el diagnóstico (factor reumatoideo: FR y anticuerpos contra péptidos citrulinados cíclicos de la anti-CCP) en la artritis reumatoidea (AR). Los autoanticuerpos se determinaron mediante ensayos inmunoenzimáticos en suero de 370 pacientes con AR y 200 controles. Se observó que los anticuerpos anti-MCV presentaron la mayor especificidad de todos los analizados (100%), mientras que los anticuerpos anti-PAD4 presentaron la menor sensibilidad (24%) y especificidad (95%). El 4% de los individuos seronegativos a FR y anti-CCP fue seropositivo a anti-MCV o PAD4. Los pacientes triples seropositivos (FR, anti-CCP y anti-MCV) presentaron mayor inflamación sistémica/articular y actividad clínica que los que expresaron otras combinaciones de autoanticuerpos (p<0,001). Por otra parte, los pacientes sólo positivos a FR cursaron con menor inflamación y actividad clínica (p<0,001). En conclusión, la inclusión de los anticuerpos anti-MCV al panel utilizado para el diagnóstico de la AR (FR y anti-CCP) podría mejorar el diagnóstico oportuno de los individuos, principalmente en aquellos pacientes seronegativos a FR y anti-CCP. Por otra parte, existen perfiles de autoanticuerpos asociados a la actividad clínica de los pacientes.


In this paper it was evaluated the clinical relevance of analyzing together two new autoantibodies (anti-mutated citrullinated vimentin: anti-MCV and anti-peptidyl arginine deiminase type 4: anti-PAD4) and those used classically in the diagnosis (rheumatoid factor: RF and antibodies against cyclic citrullinated peptide: anti-CCP) of rheumatoid arthritis (RA). The autoantibodies were examined by immunoenzymatic assays in sera of 370 patients with RA and 200 controls. It was observed that anti-MCV antibodies have the highest level of specificity of all the analyzed (100%), while the anti-PAD4 antibodies have the lowest sensitivity (24%) and specificity (95%). Four percent of the individuals that were seronegative for RF and anti-CCP were seropositive for anti-MCV or PAD4. Triple seropositive patients (RF, anti-CCP, and anti-MCV) have greater systemic/ joint inflammation and clinical activity than those with other combinations of autoantibodies (p<0.001). Patients who are only positive for FR had less inflammation and clinical activity (p<0.001). In conclusion, the inclusion of anti-MCV antibodies into the panel used for the diagnosis of RA (RF and anti-CCP) could improve the early diagnosis of individuals, mainly in patients that were seronegative for RF and anti-CCP. On the other hand, there are profiles of autoantibodies associated with the clinical activity of RA patients.


O objetivo deste estudo foi avaliar a relevância clínica de analisar dois novos autoanticorpos (anti-vimentina citrulinada mutada: anti-MCV e anti-peptidilarginina deiminase 4: anti-PAD4) e os convencionalmente utilizados no diagnóstico (fator reumatóide: FR e anticorpos contra peptídeos citrulinados cíclicos: anti-CCP) da artrite reumatóide (AR). Os autoanticorpos foram avaliados através de ensaios imunoenzimáticos em soro de 370 doentes com AR e 200 controles. Foi observado que os anticorpos anti-MCV apresentaram o maior grau de especificidade de todos os analisados (100%), enquanto que os anticorpos anti-PAD4 apresentaram a menor sensibilidade (24%) e especificidade (95%). Quatro por cento dos indivíduos soronegativos para FR e anti-CCP foram soropositivos para anti-MCV ou PAD4. Os doentes tríplice soropositivos (FR, anti-CCP e anti-MCV) apresentam maior inflamação sistêmica/articular e atividade clínica do que aqueles com outras combinações de autoanticorpos (p<0.001). Os doentes apenas positivos para FR apresentaram menor inflamação e atividade clínica (p<0.001). Em conclusão, a inclusão dos anticorpos anti-MCV para o painel utilizado para o diagnóstico de AR (FR e anti-CCP) poderia melhorar o diagnóstico oportuno dos indivíduos, principalmente daqueles que são soronegativos para FR e anti-CCP. Por outro lado, existem perfis de autoanticorpos associados à atividade clínica de doentes.


Subject(s)
Humans , Arthritis, Rheumatoid , Arthritis, Rheumatoid/complications , Autoantibodies , Autoimmune Diseases , Data Interpretation, Statistical
20.
Rev. bras. reumatol ; 57(6): 545-556, Nov.-Dec. 2017. tab
Article in English | LILACS | ID: biblio-899471

ABSTRACT

Abstract Introduction: Fatigue, anxiety and depression are very frequent symptoms in patients with rheumatoid arthritis (RA). Goals: In this study we evaluated the influence of socioeconomic characteristics, therapy and comorbidities on the self-reported high fatigue, anxiety and depression in patients with RA. Method: Multicenter cross-sectional study was performed in 22 health institutions in Serbia during the period from April-August 2014 in population of older RA patients. Self-reported patients health status was measured by: Fatigue Assessment Scale, Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7. Treatment modalities were defined as: (1) non-steroidal anti-inflammatory drugs (NSAIDs) and/or analgesics and/or corticosteroids; (2) synthetic disease-modifying antirheumatic drugs (DMARDs) alone or in combination with corticosteroids and/or NSAIDs and (3) any RA treatment which includes biologic DMARDs. Results: There were significant predictors of high depression: synthetic DMARDs therapy in combination with corticosteroids and/or NSAIDs, physiotherapist self-payment, frequent taxi use, alternative treatment and employment status. The need for another person's assistance, supplemental calcium therapy and professional qualifications were the predictors of a high fatigue, whereas the age above 65 years had the protective effect on it. Anxiety was an independent high fatigue predictor. The predictors of a high anxiety were: gastroprotection with proton-pump inhibitors and patient occupation. Conclusion Socioeconomic predictors of self-reported high depression, anxiety or fatigue are different for each of the mentioned outcomes, while accompanied with the basic RA treatment they exclusively explain a high depression. The anxiety, jointed with the socioeconomic variables and supplemental therapy, is a significant fatigue predictor in RA patients.


Resumo Introdução: A fadiga, a ansiedade e a depressão são sintomas muito frequentes em pacientes com artrite reumatoide (AR). Objetivos: Neste estudo, avaliou-se a influência de características socioeconômicas, características de tratamento e comorbidades na elevação na fadiga, ansiedade e depressão autorrelatadas em pacientes com AR. Método: Este estudo transversal multicêntrico foi feito em 22 instituições de saúde na Sérvia de abril a agosto de 2014 na população de pacientes idosos com AR. O status de saúde autorrelatado dos pacientes foi medido pelos instrumentos Fatigue Assessment Scale, Patient Health Questionnaire-9 e Generalized Anxiety Disorder-7. As modalidades de tratamento foram definidas como: 1) anti-inflamatórios não esteroides (AINE) e/ou analgésicos e/ou corticosteroides; 2) fármacos antirreumáticos modificadores da doença sintéticos (DMARD) isoladamente ou em combinação com corticosteroides e/ou AINE e 3) qualquer tratamento para a AR que incluísse DMARD biológicos. Resultados: Houve preditores significativos de depressão elevada: tratamento com DMARD sintéticos em combinação com corticosteroides e/ou AINE, pagamento particular de fisioterapia, uso frequente de serviços de táxi, terapias alternativas e status ocupacional. A necessidade de assistência de outra pessoa, o tratamento suplementar com cálcio e as qualificações profissionais foram os preditores de fadiga elevada. A idade acima de 65 anos teve um efeito protetor sobre a fadiga elevada. A ansiedade foi um preditor independente de fadiga elevada. Os preditores ansiedade elevada foram: gastroproteção com inibidores da bomba de prótons e ocupação do paciente. Conclusão: Os preditores socioeconômicos de níveis elevados de depressão, ansiedade ou fadiga autorrelatadas são diferentes para cada um dos desfechos mencionados; quando acompanhados do tratamento básico para a AR, esses preditores socioeconômicos explicam exclusivamente uma depressão elevada. A ansiedade, associada às variáveis socioeconômicas e ao tratamento complementar, é um importante preditor da fadiga em pacientes com AR.


Subject(s)
Humans , Male , Female , Aged , Anxiety/etiology , Arthritis, Rheumatoid/psychology , Socioeconomic Factors , Depression/etiology , Fatigue/etiology , Anxiety/psychology , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/drug therapy , Quality of Life , Biological Factors/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cross-Sectional Studies , Adrenal Cortex Hormones/therapeutic use , Antirheumatic Agents/therapeutic use , Depression/psychology , Fatigue/psychology , Self Report , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL